ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Subscribe to this list via RSS Blog posts tagged in VH2012

Despite a delayed flight, a bumpy trip across the Tasman and arriving in Auckland at 3:30am this morning, today’s Hepatitis Nursing Workshop (bolstered by several coffees) was a great start to the 8th Australasian Viral Hepatitis Conference. Initially, I was wondering how the Workshop would address the learning needs of both New Zealand and Australian nurses, however I felt that the speakers were very inclusive and considerate of different clinical contexts, and the concepts discussed were relevant to both sides of the Tasman.

Underpinning many presentations was an exploration of the viral hepatitis nursing role and how it is constantly being redefined. Val Honeyman, from the Hepatoma Service at Auckland City Hospital, presented on the recent and rapid change in her role, moving from absorbing HCC into her existing liver transplant coordinator role, to a dedicated HCC coordinator nursing role, to manage the increase in referral rates from 3-5/month in 2005 to 13/month currently.

Professor Ed Gane suggested that it won’t be long until nurse-led clinics will be managing cirrhosis and associated complications, not focusing on treatment as the role demands now. Janet Catt, Clinical Nurse Specialist from London, discussed the different prescribing models for viral hepatitis in the UK, including nurse and pharmacist prescribers and their role in prescribing triple therapy and managing the associated side effects. Janet also explained that all Fibroscan readings are conducted by nurses in her service. In the afternoon, Kelly Barclay from Hepatitis Foundation of NZ described the role of the new community based hepatitis nursing roles (and secondary care nurses), integral components of the new hepatitis C model of care pilot, coordinated by the Hepatitis Foundation of NZ. There was also frequent mention throughout the day of multidisciplinary teams and the benefits of working collaboratively.

The nursing role in viral hepatitis and associated complications is undeniably in a state of flux and it is exciting to see this discussed in an Australasian forum.

Thankfully, Val Honeyman also included in her session the point that research shows that caffeine intake reduces HCC risk, so in the interest of my liver health, I am off to find another coffee to see me through the evening.


Tagged in: VH2012

Posted by on in Uncategorised Posts

Thought I would try a test post before tomorrow.

Sitting here highlighter in hand, looking over the program, there is so much on, its hard to decide which sessions to attend.

Do I rush between one presentation at a time or stay for the whole session?

I've already marked a couple of presentations looking at hepatitis b in the Maori population, HCC in the northern territory and perhaps I am being a bit biased underlining the launch of the AHA Consensus Based Guidelines tomorrow morning. Even so, I am looking forward to a busy and interesting few days ahead!


Tagged in: VH2012

Posted by on in Uncategorised Posts

Professor Ed Gane says that there is no need for liver biopsy for assessing staging of hepatitis C in New Zealand. 

The cost of the flight within New Zealand to a liver clinic with a fibroscan is justified, he believes. 

Patients don't want a biopsy, and fibroscan has shown itself to be an effective tool for assessing fibrosis. 

Tagged in: VH2012

Get involved in AVHC 2012  - Sign the Auckland Statement NOW!

Show your support


Tagged in: VH2012
Twitter response: "Could not authenticate you."